Johnson & Johnson (JNJ) stock drops 1.8% on revenue miss

Though revenue grew 10% YoY, Johnson & Johnson (JNJ) reported Q4 revenue of $24.8 billion on Tuesday morning that came in $500 million below optimistic analyst consensus. Dropping 1.8% on the news, JNJ stock is trading at $159.97 in the premarket.
The healthcare powerhouse reported adjusted earnings per share (EPS) of $2.13, which was just above Wall Street forecasts.
Premium
You have reached your limit of 3 free articles for this month.
Start your subscription and get access to all our original articles.
Author

Clay Webster
FXStreet
Clay Webster grew up in the US outside Buffalo, New York and Lancaster, Pennsylvania. He began investing after college following the 2008 financial crisis.

















